Mr. Ilan Sobel reports

BIOHARVEST SCIENCES INC. ANNOUNCES A PRIVATE PLACEMENT OF UP TO $13.5 MILLION OF CONVERTIBLE NOTES

Bioharvest Sciences Inc. has issued a correction to an error in its news release from Oct. 19, 2023. The non-brokered private placement of convertible notes is for proceeds of up to $13.5-million, not $12-million. All other information remains the same.

About Bioharvest Sciences Inc.

Bioharvest Sciences is a fast-growing biotechnology firm listed on the Canadian Securities Exchange. Bioharvest has developed a patented biocell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at industrial scale, without the need to grow the plant itself. Bioharvest is currently focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions, within two major business verticals -- nutraceutical health and wellness products (such as dietary supplements) and development of plant-cell-based active pharmaceutical ingredients (APIs) that focus on specific medical indications.

We seek Safe Harbor.